Re: Potential Overtreatment among Men Aged 80 Years and Older with Localized Prostate Cancer in Japan

Comment

Tomas L Griebling. J Urol. 2018 Jun.

. 2018 Jun;199(6):1375.

doi: 10.1016/j.juro.2018.03.045. Epub 2018 Mar 20.

No abstract available

Comment on

Potential overtreatment among men aged 80 years and older with localized prostate cancer in Japan.
Masaoka H, Ito H, Yokomizo A, Eto M, Matsuo K. Masaoka H, et al. Cancer Sci. 2017 Aug;108(8):1673-1680. doi: 10.1111/cas.13293. Epub 2017 Jul 4. Cancer Sci. 2017. PMID: 28594447 Free PMC article.

Potential overtreatment among men aged 80 years and older with localized prostate cancer in Japan.
Masaoka H, Ito H, Yokomizo A, Eto M, Matsuo K. Masaoka H, et al. Cancer Sci. 2017 Aug;108(8):1673-1680. doi: 10.1111/cas.13293. Epub 2017 Jul 4. Cancer Sci. 2017. PMID: 28594447 Free PMC article.
Addressing overtreatment following the diagnosis of localized prostate cancer.
Tawadros T, Valerio M. Tawadros T, et al. Expert Rev Anticancer Ther. 2016;16(4):373-4. doi: 10.1586/14737140.2016.1143779. Epub 2016 Feb 12. Expert Rev Anticancer Ther. 2016. PMID: 26776104 No abstract available.
Early Stage Cancer in Older Adults: Prostate-Avoiding Overtreatment and Undertreatment.
Narayan V, Jiang S, Warlick CA. Narayan V, et al. Cancer J. 2017 Jul/Aug;23(4):238-241. doi: 10.1097/PPO.0000000000000273. Cancer J. 2017. PMID: 28731947 Review.
Current impact of age and comorbidity assessment on prostate cancer treatment choice and over/undertreatment risk.
Lunardi P, Ploussard G, Grosclaude P, Roumiguié M, Soulié M, Beauval JB, Malavaud B. Lunardi P, et al. World J Urol. 2017 Apr;35(4):587-593. doi: 10.1007/s00345-016-1900-9. Epub 2016 Jul 21. World J Urol. 2017. PMID: 27443847
Management of older men with clinically localized prostate cancer: the significance of advanced age and comorbidity.
Hoffman KE. Hoffman KE. Semin Radiat Oncol. 2012 Oct;22(4):284-94. doi: 10.1016/j.semradonc.2012.05.005. Semin Radiat Oncol. 2012. PMID: 22985811 Review.